| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Pelthos Therapeutics Inc.'s insiders have reduced their positions by a net 2,141 shares worth roughly $45K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
All 3 insiders who sold still hold shares after their sales. Classified under Biotechnology (Health Care sector), PTHS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 80.5K | $1.67M | -558 | |
| Dir | 75.8K | $2.11M | - | |
| CFO | 30.8K | - | - | |
| Dir | 27.4K | $562.5K | - | |
| Dir | 23.1K | $488.8K | -797 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2026 | Malamut Richard | Director | Sell | 590 | $20.92 | $12,340.04 | -2.1% | +37.3% | - | |
| Apr 2, 2026 | Greenleaf Peter49 | Director | Sell | 797 | $20.92 | $16,669.59 | -3.1% | +37.3% | - | |
| Apr 2, 2026 | Friedberg Ezra M | Director | Sell | 558 | $20.92 | $11,670.76 | -0.7% | +37.3% | - | |
| Nov 25, 2025 | Friedberg Ezra M | Director | Sell | 10,000 | $28.03 | $280,280.50 | -25.0% | -10.0% | - | |
| Sep 13, 2024 | Francis Knuettel II68 | CEO, President, CFO, Treasurer &Secty | Buy | 5,200 | $0.97 | $5,044.00 | +1.0% | -25.6% | +251.1% | |
| Sep 12, 2024 | Malamut Richard | Director | Buy | 10,400 | $0.94 | $9,824.88 | +12.8% | -33.6% | +231.7% | |
| Sep 11, 2024 | Francis Knuettel II68 | CEO, President, CFO, Treasurer &Secty | Buy | 12,000 | $0.91 | $10,955.00 | +2.3% | -35.4% | +233.2% |